Stem Cell Related Donor Safety Study (RDSafe)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00948636|
Recruitment Status : Completed
First Posted : July 29, 2009
Last Update Posted : June 14, 2017
The study tests the hypothesis that related hematopoietic stem cell donors are at a higher risk for acute medical and psychological toxicity associated with the donation process compared to adult unrelated hematopoietic stem cell donors.
The study will also assess the hypothesis that young (<18 years) and older (>60 years) related donors are at increased risk for toxicity associated with donation compared to younger adult donors by describing the adverse events reported in these populations.
An ancillary study of the psychological impact of donation on health-related quality of life (HRQoL) will enroll related donors and compare them to an age-matched normative cohort.
|Condition or disease|
|Related Hematopoietic Stem Cell Donors|
|Study Type :||Observational|
|Actual Enrollment :||1812 participants|
|Official Title:||A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life|
|Study Start Date :||January 2010|
|Actual Primary Completion Date :||August 2015|
|Actual Study Completion Date :||September 2016|
Related Hematopoietic Stem Cell Donors
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00948636
Show 52 Study Locations
|Principal Investigator:||Michael A Pulsipher, M.D.||Children's Hospital Los Angeles|